title: Posterior reversible encephalopathy syndrome after bevacizumab treatment presenting to the ED as chest pain and headache.
authors.affiliation: University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030. Electronic address: ahmiller@mdanderson.org.
authors.forename: A H
authors.initials: AH
authors.lastname: Miller
authors.affiliation: University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030.
authors.forename: J A
authors.initials: JA
authors.lastname: Monteiro de Oliveira Novaes
authors.affiliation: University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030.
authors.forename: P A
authors.initials: PA
authors.lastname: Brock
authors.affiliation: University of Texas MD Anderson Cancer Center, Division of Internal Medicine, Department of Emergency Medicine, Unit 1468, Houston, TX 77030.
authors.forename: M
authors.initials: M
authors.lastname: Sandoval
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068258:Bevacizumab / Q000009:adverse effects*; D001921:Brain / Q000000981:diagnostic imaging; D002277:Carcinoma / Q000188:drug therapy / Q000556:secondary; D002637:Chest Pain / Q000209:etiology; D005260:Female; D006261:Headache / Q000209:etiology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced* / Q000150:complications / Q000000981:diagnostic imaging
chemical_list: D000970:Antineoplastic Agents; D000068258:Bevacizumab